跳至主要内容
临床试验/NCT07602803
NCT07602803已完成不适用

GLP1 Agonists Once Weekly for the Treatment of Obesity in Patients With Bardet-Biedl Syndrome (BBS)

The Queen Elizabeth Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2023年1月1日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
1

研究概览

简要总结

The goal of this observational study is to learn about the long-term effects of GLP1 agonists (weight loss jab, including Mounjaro) in patients with Bardet-Biedl Syndrome (BBS) who take GLP1 agonists to treat high body weight. The main question:

Do GLP1 agonists effectively and safely lower body weight in patients with BBS when taken long-term, compared to patients not on these medications? The investigators look at the change (%) in weight during the observational periods.

详细描述

Demographics on time zero: Age, gender, Race, Body Weight (BW), Body Mass Index (BMI), Blood Pressure (clinic, DM meds), Pulse, Lipid profiles (Chol, HDL, LDL, TG), eGFR, HBA1c, (if feasible) genetic diagnosis

Primary outcome at the end of study date : Body weight change (%)

Secondary outcome at the end of study date: change in lipid (Chol, HDL, LDL, TG), Blood Pressure, DM status

Quality assurance plan: data validation will be secured due to the electronic record. The registry process was undertaken in our closed national BBS centres quality assured by multi-disciplinary team (MDT) looked after by senior specialty nurses, who followed all the patients with GLP1 agonists monthly over the telephone.

Data checks to compare data entered into the registry against predefined rules for range or consistency with other data fields in the registry.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All the adult patients with a genetic diagnosis of BBS under the national BBS centres (London and Birmingham in the UK).

排除标准

  • Adult patients with a genetic diagnosis of BBS under the national BBS centres (London and Birmingham in the UK) who lost follow ups or significant missing data, or BMI<30 in patients without GLP1 agonists.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuki Heath

Specialty Doctor in Renal Medicine

The Queen Elizabeth Hospital

研究点 (1)

Loading locations...

相似试验

The Effect of GLP1 Agonists on Weight Loss in BBS... | 临床试验